IL197908A0 - Buprenorphine-containing non-pressurised spray composition for transmucosal administration - Google Patents
Buprenorphine-containing non-pressurised spray composition for transmucosal administrationInfo
- Publication number
- IL197908A0 IL197908A0 IL197908A IL19790809A IL197908A0 IL 197908 A0 IL197908 A0 IL 197908A0 IL 197908 A IL197908 A IL 197908A IL 19790809 A IL19790809 A IL 19790809A IL 197908 A0 IL197908 A0 IL 197908A0
- Authority
- IL
- Israel
- Prior art keywords
- buprenorphine
- containing non
- transmucosal administration
- spray composition
- pressurised spray
- Prior art date
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 title 1
- 229960001736 buprenorphine Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007921 spray Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0620661.9A GB0620661D0 (en) | 2006-10-18 | 2006-10-18 | Novel compounds |
PCT/GB2007/050639 WO2008047163A1 (en) | 2006-10-18 | 2007-10-17 | Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
IL197908A0 true IL197908A0 (en) | 2009-12-24 |
Family
ID=37507923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL197908A IL197908A0 (en) | 2006-10-18 | 2009-04-05 | Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2081574A1 (en) |
CN (1) | CN101573116A (en) |
AU (1) | AU2007311621A1 (en) |
CA (1) | CA2666581A1 (en) |
GB (2) | GB0620661D0 (en) |
IL (1) | IL197908A0 (en) |
WO (1) | WO2008047163A1 (en) |
ZA (1) | ZA200902123B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
SI2054031T1 (en) | 2006-07-21 | 2016-09-30 | Biodelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
GB2461681A (en) * | 2008-04-17 | 2010-01-13 | Pharmasol Ltd | Buprenorphine liquid spray formulation with solvent and antioxidant |
ES2562878T3 (en) | 2007-05-25 | 2016-03-08 | Indivior Uk Limited | Sustained release formulations of risperidone compounds |
WO2010072398A2 (en) * | 2008-12-22 | 2010-07-01 | Boehringer Ingelheim Limited | Veterinary formulations |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
GB2481619B (en) * | 2010-06-30 | 2012-06-20 | Londonpharma Ltd | Formulations and delivery devices for the sublingual administration of opioids |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
WO2013096811A2 (en) * | 2011-12-21 | 2013-06-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
WO2017075256A1 (en) | 2015-10-27 | 2017-05-04 | Insys Development Company, Inc. | Liquid buprenorphine formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030190290A1 (en) * | 2000-06-22 | 2003-10-09 | Calvin Ross | Pharmaceutical compositions |
JP2005503425A (en) * | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | Delivery of drug ester by the prescribed inhalation route |
JP2006516963A (en) * | 2003-02-04 | 2006-07-13 | クリサリス テクノロジーズ インコーポレイテッド | Aerosol formulation and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem |
EP1745247B1 (en) * | 2004-04-23 | 2015-11-11 | Philip Morris Products S.a.s. | Aerosol generators and methods for producing aerosols |
-
2006
- 2006-10-18 GB GBGB0620661.9A patent/GB0620661D0/en not_active Ceased
-
2007
- 2007-10-17 WO PCT/GB2007/050639 patent/WO2008047163A1/en active Application Filing
- 2007-10-17 CN CNA2007800387417A patent/CN101573116A/en active Pending
- 2007-10-17 EP EP07824851A patent/EP2081574A1/en not_active Withdrawn
- 2007-10-17 CA CA002666581A patent/CA2666581A1/en not_active Abandoned
- 2007-10-17 AU AU2007311621A patent/AU2007311621A1/en not_active Abandoned
-
2009
- 2009-03-25 GB GB0905120A patent/GB2456434A/en not_active Withdrawn
- 2009-03-26 ZA ZA200902123A patent/ZA200902123B/en unknown
- 2009-04-05 IL IL197908A patent/IL197908A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008047163A1 (en) | 2008-04-24 |
AU2007311621A1 (en) | 2008-04-24 |
GB0620661D0 (en) | 2006-11-29 |
CN101573116A (en) | 2009-11-04 |
GB0905120D0 (en) | 2009-05-06 |
GB2456434A (en) | 2009-07-22 |
EP2081574A1 (en) | 2009-07-29 |
CA2666581A1 (en) | 2008-04-24 |
ZA200902123B (en) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL197908A0 (en) | Buprenorphine-containing non-pressurised spray composition for transmucosal administration | |
EP2001498A4 (en) | Pharmaceutical compositions | |
IL194176A0 (en) | Pharmaceutical compositions | |
GB0625322D0 (en) | Pharmaceutical compositions | |
SI2101740T1 (en) | New non-abusable pharmaceutical composition comprising opioids | |
IL195246A0 (en) | Atomiser | |
HK1138732A1 (en) | Pharmaceutical compositions | |
ZA200710734B (en) | Compositions for drug delivery | |
IL248492A0 (en) | Pharmaceutical compositions for intraventricular delivery | |
GB0610322D0 (en) | Novel pharmaceutical compositions | |
GB0608724D0 (en) | Novel Pharmaceutical Compositions | |
ZA200806929B (en) | Nebulizer formulation | |
ZA201103347B (en) | Pharmaceutical aerosol composition | |
GB0621494D0 (en) | Betamethasone spray | |
EP2124959A4 (en) | Pharmaceutical composition | |
EP2097074A4 (en) | Topical pharmaceutical composition | |
EP2109454A4 (en) | Glp-1 pharmaceutical compositions | |
GB2443161B (en) | Clobetasol spray | |
GB0515212D0 (en) | Compositions for intranasal administration | |
GB0617578D0 (en) | Pharmaceutical composition | |
GB0600032D0 (en) | Pharmaceutical composition | |
GB0612696D0 (en) | Pharmaceutical composition | |
ZA200904725B (en) | GLP-1 Pharmaceutical compositions | |
GB0609941D0 (en) | Pharmaceutical compositions | |
GB0621623D0 (en) | Pharmaceutical compositions |